DNA damage is increased in lymphocytes of patients with metabolic syndrome

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 782, Issue , 2015, Pages 30-35

  Karaman, Ali ^a   Aydin, Hatip ^a   Geçkinli, Bilge ^a   Çetinkaya, Arda ^a   Karaman, Selin ^b  

^a Clinic of Obstetrics and Gynecology   (Turkey)

^b DR LUTFI KIRDAR KARTAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Comet assay; DNA damage; Metabolic syndrome; Micronucleus assay

Indexed keywords

GLUCOSE BLOOD LEVEL; GLUTATHIONE PEROXIDASE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; AGED; BLOOD; BLOOD PRESSURE; BODY MASS; COMET ASSAY; DNA DAMAGE; FEMALE; GENETICS; GLUCOSE BLOOD LEVEL; HUMAN; LYMPHOCYTE; MALE; METABOLIC SYNDROME X; METABOLISM; MICRONUCLEUS TEST; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL, HDL; COMET ASSAY; DNA DAMAGE; FEMALE; GLUTATHIONE PEROXIDASE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LYMPHOCYTES; MALE; MALONDIALDEHYDE; METABOLIC SYNDROME X; MICRONUCLEUS TESTS; MIDDLE AGED; OBESITY, ABDOMINAL; SUPEROXIDE DISMUTASE; TRIGLYCERIDES; YOUNG ADULT;

EID: 84931392416     PISSN: 13835718     EISSN: 18793592     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2015.03.009     Document Type: Article

References (45)

1. Alberti K.G., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., Fruchart J.C., Loria C.M., Smith S.C. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645.
2. Amos A., McCarty D., Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabetic Med. 1997, 14:S1-S85.
3. Vassalle C., Pratali L., Boni C., Mercuri A., Ndreu R. Agerelated oxidative stress modulation by smoking habit and obesity. Clin. Biochem. 2008, 41:1162-1167.
4. Lawlor D.A., Lean M., Sattar N. ABC of obesity: obesity and vascular disease. BMJ 2006, 333:1060-1063.
5. Demirbag R., Yilmaz R., Gur M., Celik H., Guzel S., Selek S., Kocyigit A. DNA damage in metabolic syndrome and its association with antioxidative and oxidative measurements. Int. J. Clin. Pract. 2006, 60:1187-1193.
6. Moran L.J., Noakes M., Clifton P.M., Norman R.J., Fenech M.F. Genome instability is increased in lymphocytes of women with polycystic ovary syndrome and is correlated with insulin resistance. Mutat. Res. 2008, 639:55-63.
7. Yesilada E., SahinI I., Ozcan H., Yildirim I.H., Yologlu S., Taskapan C. Increased micronucleus frequencies in peripheral blood lymphocytes in women with polycystic ovary syndrome. Eur. J. Endocrinol. 2006, 154:563-568.
8. Hamurcu Z., Bayram F., Kahriman G., Dönmez-Altuntas H., Baskol G. Micronucleus frequency in lymphocytes and 8-hydroxydeoxyguanosine level in plasma of women with polycystic ovary syndrome. Gynecol. Endocrinol. 2010, 26:590-595.
9. Goodarz M.O., Azziz R. Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome. Best Pract. Res. Clin. Endocrinol. Metab. 2006, 20:93-205.
10. Packer L., Kraemer K., Rimbach G. Molecular aspects of lipoic acid in the prevention of diabetes complications. Nutrition 2001, 17:888-895.
11. Anderson D., Plewa M.J. The international comet assay workshop. Mutagenesis 1998, 13:67-73.
12. Hwang E.S., Kim G.H. Biomarkers for oxidative stress status of DNA, lipids, and proteins in vitro and in vivo cancer research. Toxicology 2007, 229:1-10.
13. Toperoff G., Aran D., Kark J.D., Rosenberg M., Dubnikov T., Nissan B., Wainstein B.J., Friedlander Y., Levy-Lahad E., Glaser B., Hellman A. Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood. Hum. Mol. Genet. 2012, 21:371-383.
14. Kirsch-Volders M., Sofuni T., Aardema M., Albertini S., Eastmond D., Fenech M., Ishidate M., Kirchner S., Lorge E., Morita T., Norppa H., Surralles J., Vanhauwaert A., Wakata A. Report from the in vitro micronucleus assay working group. Mutat. Res. 2003, 540:153-163.
15. Bonnes-Tourel D., Guerin M.C., Torreilles J. Is malondialdehyde a valuable indicator of lipid peroxidation?. Biochem. Pharmacol. 1992, 44:985-988.
16. Oktyabrsky O.N., Smirnova G.V. Redox regulation of cellular functions. Biochemistry 2007, 72:132-145.
17. Fenech M. Cytokinesis-block micronucleus cytome assay. Nat. Protoc. 2007, 2. 1084-1104; 1033-1043.
18. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 1988, 175:184-191.
19. Pompella A., Maellora E., Casini A.F., Ferrali M., Ciccoli L., Comporti M. Measurement of lipid peroxidation in vivo: a comparison of different procedures. Lipids 1987, 22:206-211.
20. Sun Y., Oberley L.W., Li Y. A simple method for clinical assay of superoxide dismutase. Clin. Chem. 1988, 34:497-500.
21. Paglia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 1967, 70:158-169.
22. Ode K.L., Frohnert B.I., Nathan B.M. Identification and treatment of metabolic complications in pediatric obesity. Rev. Endocr. Metab. Disord. 2009, 10:167-188.
23. Bukhari S.A., Rajoka M.I., Nagra S.A., Rehman Z.U. Plasma homocysteine and DNA damage profiles in normal and obese subjects in the Pakistani population. Mol. Biol. Rep. 2010, 37:289-295.
24. Cadenas E. Review Biochemistry of oxygen toxicity. Annu. Rev. Biochem. 1989, 58:79-110.
25. Sena L.A., Chandel N.S. Review physiological roles of mitochondrial reactive oxygen species. Mol. Cell 2012, 48:158-167.
26. Dreher D., Junod A.F. Role of oxygen free radicals in cancer development. Eur. J. Cancer 1996, 32A:30-38.
27. Vincent H.K., Innes K.E., Vincent K.R. Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity. Diabetes Obes. Metab. 2007, 9:813-839.
28. Iozzo P. Viewpoints on the way to the consensus session: where does insulin resistance start? The adipose tissue. Diabetes Care 2009, 32:S168-S173.
29. Andreassi M.G. DNA damage vascular senescence, and atherosclerosis. J. Mol. Med. 2008, 86:1033-1043.
30. Lesgards J.F., Durand P., Lassarre M., Stocker P., Lesgards G., Lanteaume A., Prost M., Lehucher-Michel M.P. Assessment of lifestyle effects on the overall antioxidant capacity of healthy subjects. Environ. Health Perspect. 2002, 110:479-486.
31. Robertson R.P. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J. Biol. Chem. 2004, 279:42351-42354.
32. Ceriello A. Acute hyperglycaemia and oxidative stress generation. Diabet. Med. 1997, 14:S45-S49.
33. Basu S. Radioimmunoassay of 15-keto-13,14-dihydro-prostaglandin F2alpha: an index for inflammation via cyclooxygenase catalysed lipid peroxidation. Prostaglandins Leukot. Essent. Fatty Acids 1998, 58:347-352.
34. Davì G., Falco A., Patrono C. Lipid peroxidation in diabetes mellitus. Antioxid. Redox Signaling 2005, 7:256-268.
35. 2-induced higher order chromatin degradation: a novel mech anism of oxidative genotoxicity. J. Biosci. 2003, 28:57-60.
36. Mitjavila M.T., Fandos M., Salas-Salvadó J., Covas M.I., Borrego S., Estruch R., Lamuela-Raventós R., Corella D., Martínez-Gonzalez M.A., Sánchez J.M., Bulló M., Fitó M., Tormos C., Cerdá C., Casillas R., Moreno J.J., Iradi A., Zaragoza C., Chaves J., Sáez G.T. The Mediterranean diet improves the systemic lipid and DNA oxidative damage in metabolic syndrome individuals. Clin. Nutr. 2013, 32:172-178.
37. Rehman A., Nourooz-Zadeh J., Möller W., Tritschler H., Pereira P., Halliwell B. Increased oxidative damage to all DNA bases in patients with type II diabetes mellitus. FEBS Lett. 1999, 448:120-122.
38. Binici D.N., Karaman A., Coşkun M., Oğlu A.U., Uçar F. Genomic damage in patients with type-2 diabetes mellitus. Genet. Couns. 2013, 24:149-156.
39. Lodovici M., Giovannelli L., Pitozzi V., Bigagli E., Bardini G., Rotella C.M. Oxidative DNA damage and plasma antioxidant capacity in type 2 diabetic patients with good and poor glycaemic control. Mutat. Res. 2008, 638:98-102.
40. Jennings P.E., Scott N.A., Saniabadi A.R., Belch J.J. Effects of gliclazide on platelet reactivity and free radicals in type II diabetic patients: clinical assessment. Metabolism 1992, 41:36-39.
41. Oranje W.A., Rondas-Colbers G.J., Swennen G.N., Jansen H., Wolffenbuttel B.H. Lack of effect on LDL oxidation and antioxidant status after improvement of metabolic control in type 2 diabetes. Diabetes Care 1999, 22:2083-2084.
42. Cakatay U. Protein oxidation parameters in type 2 diabetic patients with good and poor glycaemic control. Diabetes Metab. 2005, 31:551-557.
43. Dandona P., Thusu P.K., Cook S., Snyder B., Makowski J., Armstrong D., Nicotera T. Oxidative damage to DNA in diabetes mellitus. Lancet 1996, 347:444-445.
44. Ruhe R.C., McDonald R.B. Use of antioxidant nutrients in the prevention and treatment of type 2 diabetes. J. Am. Coll. Nutr. 2001, 20. 363S-369S; 381S-383S.
45. Huang P., Huang B., Weng H., Nakayama K., Morimoto K. Effects of lifestyle on micronuclei frequency in human lymphocytes in Japanese hard-metal workers. Prev. Med. 2009, 48:383-388.